A Double-Blind, Placebo-Controlled Study of Selegiline Transdermal System (STS) in Depressed Adolescents

Thursday, October 20, 2011

Melissa P. DelBello, M.D., M.S., Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH

Thomas J. Hochadel, Pharm.D., Cognitive Research Corporation, Saint Petersburg, FL

Kimberly B. Portland, Ph.D., Medical Affairs, Dey Pharma, L. P., Basking Ridge, NJ

Sunil Mehra, M.D., Medical Affairs, Dey Pharma, L. P., Basking Ridge, NJ

Arif Khan, M.D., Northwest Clinical Research Center, Bellevue, WA

Alain Katic, M.D., Houston, TX

Graham J. Emslie, M.D., University of Texas Southwestern Medical Center at Dallas, Dallas, TX


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 2.20 A Double-Blind, Placebo-Controlled Study of Selegiline Transdermal System (STS) in Depressed Adolescents